Literature DB >> 18655947

Noninvasive positive pressure ventilation in the emergency department.

Mei-Ean Yeow1, Jairo I Santanilla.   

Abstract

Noninvasive positive pressure ventilation (NPPV) is becoming more commonplace, both in the ICU and also in the Emergency Department. This article addresses the rationale and mechanism of action for NPPV. A review of the indications for using NPPV and a discussion detailing the initiation of NPPV follows. NPPV has been shown to decrease length of hospital stay and the need for intubation in patients who have chronic obstructive pulmonary disease and acute cardiogenic pulmonary edema. NPPV should be considered for most patients who have respiratory distress who are being considered for intubation. After NPPV is initiated, very close monitoring and follow-up must be employed to identify those patients who are at risk for treatment failure.

Entities:  

Mesh:

Year:  2008        PMID: 18655947     DOI: 10.1016/j.emc.2008.04.005

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  4 in total

Review 1.  Noninvasive ventilation for acute respiratory failure: a review of the literature and current guidelines.

Authors:  Katherine Margaret Berg; Peter Clardy; Michael William Donnino
Journal:  Intern Emerg Med       Date:  2012-09-28       Impact factor: 3.397

2.  Aspiration pneumonia after stroke: intervention and prevention.

Authors:  John R Armstrong; Benjamin D Mosher
Journal:  Neurohospitalist       Date:  2011-04

3.  Vascular pedicle width on chest radiograph as a measure of volume overload: meta-analysis.

Authors:  Hao Wang; Runhua Shi; Simon Mahler; Joseph Gaspard; Julie Gorchynski; James D'Etienne; Thomas Arnold
Journal:  West J Emerg Med       Date:  2011-11

4.  Combined noninvasive ventilation and mechanical insufflator-exsufflator for acute respiratory failure in patients with neuromuscular disease: effectiveness and outcome predictors.

Authors:  Tai-Heng Chen; Wen-Chen Liang; I-Chen Chen; Yi-Ching Liu; Jong-Hau Hsu; Yuh-Jyh Jong
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.